FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to an aerosol pharmaceutical composition for preventing or treating a patient suffering chronic obstructive pulmonary disease (COPD), which is stored in a container, to using the above composition for treating COPD, to a method for filling the above container, to a kit for preventing or treating COPD. The declared composition contains glycopyrronium chloride, formoterol dissolved in the propellant hydroxyfluoralkane, and 1M HCl.
EFFECT: glycopyrronium chloride, formoterol and an optional steroid are completely dissolved in the propellant mixture, and the composition is stable for three months.
7 tbl, 17 cl
